S279 point mutations in Candida albicans Sterol 14-alpha demethylase (CYP51) reduce in vitro inhibition by fluconazole.
(17/31)
(+info)
Tissue distribution of vitamin E metabolites in rats after oral administration of tocopherol or tocotrienol.
(18/31)
We previously found that 2,7,8-trimethyl-2(2'-carboxyethyl)-6-hydroxychroman (gammaCEHC), a metabolite of the vitamin E isoforms gamma-tocopherol or gamma-tocotrienol, accumulated in the rat small intestine. The aim of this study was to evaluate tissue distribution of vitamin E metabolites. A single dose of alpha-tocopherol, gamma-tocopherol or a tocotrienol mixture containing alpha- and gamma-tocotrienol was orally administered to rats. Total amounts of conjugated and unconjugated metabolites in the tissues were measured by HPLC with an electrochemical detector, and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox) was used as an internal standard. Twenty-four hours later, the vitamin E isoforms were detected in most tissues and in the serum. However, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman (alphaCEHC), a metabolite of alpha-tocopherol or alpha-tocotrienol, and gammaCEHC accumulated in the serum and in some tissues including the liver, small intestine and kidney. Administration of alpha-tocopherol increased the gammaCEHC concentration in the small intestine, suggesting that alpha-tocopherol enhances gamma-tocopherol catabolism. In contrast, ketoconazole, an inhibitor of cytochrome P450 (CYP)-dependent vitamin E catabolism, markedly decreased the gammaCEHC concentration. These data indicate that vitamin E metabolite accumulates not only in the liver but also in the small intestine and kidney. We conclude that some dietary vitamin E is catabolized to carboxyethyl-hydroxychroman in the small intestine and is secreted into the circulatory system. (+info)
Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
(19/31)
(+info)
Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.
(20/31)
(+info)
The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes.
(21/31)
(+info)
Disappearance of pituitary macro adenoma with combination of ketoconazole and cabergoline treatment: an unusual case of Cushing's syndrome with interesting findings.
(22/31)
(+info)
Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnib.
(23/31)
(+info)
Isolated Cushing's syndrome in early infancy due to left adrenal adenoma: an unusual aetiology.
(24/31)
(+info)